4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-014727
President and CEO acquired 5 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2017-12-13 | Grant or award | +5 | $20.47 | $102 | 12,505 | D |
| Derivatives | |||||||
| Watts Ryan J. President and CEO | 2018-02-26 | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | D | ||
Loading xslF345X03/doc4.xml…